Co-administration of treatment for drug-resistant TB and hepatitis C.

Olaru, I D; Beliz Meier, M; Schumacher, S G; Prodanovic, N; Kitchen, P J; Mirzayev, F; Denkinger, C M

Olaru, I D; Beliz Meier, M; Schumacher, S G; Prodanovic, N; Kitchen, P J; Mirzayev, F; Denkinger, C M.

Afiliação

Olaru ID; Division of Infectious Disease and Tropical Medicine, Heidelberg University Hospital, Heidelberg, Germany, Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK.
Beliz Meier M; Division of Infectious Disease and Tropical Medicine, Heidelberg University Hospital, Heidelberg, Germany.
Schumacher SG; Global TB Programme, World Health Organization, Geneva, Switzerland.
Prodanovic N; Division of Infectious Disease and Tropical Medicine, Heidelberg University Hospital, Heidelberg, Germany.
Kitchen PJ; Division of Infectious Disease and Tropical Medicine, Heidelberg University Hospital, Heidelberg, Germany.
Mirzayev F; Global TB Programme, World Health Organization, Geneva, Switzerland.
Denkinger CM; Division of Infectious Disease and Tropical Medicine, Heidelberg University Hospital, Heidelberg, Germany, German Center for Infection Research (DZIF), partner site Heidelberg University Hospital, Heidelberg, Germany.

Int J Tuberc Lung Dis ; 27(1): 66-68, 2023 01 01.

Article em En | MEDLINE | ID: mdl-36853135

Assuntos

Hepatite C; Tuberculose Resistente a Múltiplos Medicamentos; Humanos; Hepatite C/tratamento farmacológico; Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite C / Tuberculose Resistente a Múltiplos Medicamentos Limite: Humans Idioma: En Revista: Int J Tuberc Lung Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google